Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by André Zimerman
Conduction System vs Biventricular Pacing in Heart Failure : The PhysioSync-HF Randomized Clinical Trial
Conduction System vs Biventricular Pacing in Heart Failure: The PhysioSync-HF Randomized Clinical Trial Supplement 1. Supplement 2. Statistical Analysis Plan Supplement 3. eAppendix 1. Trial Leadership and Committees eAppendix 2. Site Investigators eMethods. Additional Details on Methods eTable 1. Procedural Characteristics and Complications eTable 2. Sensitivity Analyses for the Primary End Point eTable 3. Individual Causes of Death eTable 4. Subgroup Analysis for the Primary End Point eTable 5.
Small-Interfering RNA Olpasiran and Apolipoprotein B Particles
Apolipoprotein B (apoB)–containing lipoproteins are a key driver of atherosclerosis.
Outcomes in Older Patients After Switching to a Newer Anticoagulant or Remaining on Warfarin: The COMBINE-AF Substudy
Get full access to this article View all available purchase options and get full access to this article. Supplementary Material Supplemental Tables 1 and 2 and Supplemental Figures 1-4 (mmc1.docx) Supplemental Material (mmc2.docx) References 1. Pisters R., Lane D.A., Nieuwlaat R. A novel user-friendly score (HAS BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation. CHEST J. 2010;138:1093-1100. https://doi.org/10.1378/chest.10-0134. 2.
Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial Fibrillation: Post Hoc Analysis of the ENGAGE AF-TIMI 48 Randomized Clinical Trial | Anticoagulation | JAMA Cardiology | JAMA Network
Key Points Question Do patients 80 years and older with atrial fibrillation who are at high risk of ischemic and bleeding events benefit from lower-dose anticoagulants, even in the absence of prespecified dose-reduction criteria?
COVID-19 Vaccination and Cardiopulmonary Events After Acute Coronary Syndromes
Introduction COVID-19 vaccines effectively reduce the risk of hospitalizations and death.1,2 However, the efficacy of COVID-19 vaccines in reducing the incidence of cardiopulmonary events in a secondary prevention population at high risk of cardiovascular events remain unstudied, to our knowledge.
Revisiting heart failure assessment based on objective measures in NYHA functional classes I and II
Heart failure and cardiomyopathies Revisiting heart failure assessment based on objective measures in NYHA functional classes I and II Mariana Blacher1,2, André Zimerman1,3, Pedro H B Engster3, Eduardo Grespan3, Carisi A Polanczyk1,2,3, Marciane M Rover4, José A de Figueiredo Neto5, Luiz C Danzmann6, Eduardo G Bertoldi7, Marcus Vinicius Simões8, Luis Beck-da-Silva1,2,3, Andréia Biolo1,2,3, http://orcid.org/0000-0002-6557-393XLuis E Rohde1,2,3 1 Post-Graduate Program in Cardiology and...
Why do poor patients have poor outcomes? Shedding light on the neglected facet of poverty and heart failure
Why do poor patients have poor outcomes?
Revisiting heart failure assessment based on objective measures in NYHA functional classes I and II
Heart failure and cardiomyopathies Revisiting heart failure assessment based on objective measures in NYHA functional classes I and II Mariana Blacher1,2, André Zimerman1,3, Pedro H B Engster3, Eduardo Grespan3, Carisi A Polanczyk1,2,3, Marciane M Rover4, José A de Figueiredo Neto5, Luiz C Danzmann6, Eduardo G Bertoldi7, Marcus Vinicius Simões8, Luis Beck-da-Silva1,2,3, Andréia Biolo1,2,3, http://orcid.org/0000-0002-6557-393XLuis E Rohde1,2,3 1Post-Graduate Program in Cardiology and...
COVID-19 in Brazil: the headlines should be about science
We have all heard this story: fuelled by untimely political disputes, COVID-19 spread like wildfire in Brazil. Much attention has been given to these controversies, and understandably so: reports about the president who replies, “So what?” when asked about escalating deaths incite our curiosity and our exasperation. These are the stories everyone hears about, the stories everyone talks about, including the Editors.
Why do poor patients have poor outcomes? Shedding light on the neglected facet of poverty and heart failure
Why do poor patients have poor outcomes?
Why do poor patients have poor outcomes? Shedding light on the neglected facet of poverty and heart failure
Why do poor patients have poor outcomes? Shedding light on the neglected facet of poverty and heart failure Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways. Copyright information: © Author(s) (or their employer(s)) 2020. No commercial re-use.
Trends in New Diagnoses of Atrial Fibrillation After Release of an ECG-Capable Smartwatch
On December 6, 2018, a US Food and Drug Administration–cleared algorithm capable of detecting atrial fibrillation (AF) was released for the wearable Apple Watch Series, which also included a single-lead ECG feature for Series 4.1 Given the popularity of the device, with an estimated 53.2 million global shipments in 2018 to 2019,2 some predicted a dramatic increase in early AF diagnoses and a disruption in medical practices.
The need for speed: observational study of physician driving behaviors
Research The need for speed:...
Reporting Clinical End Points and Safety Events in an Acute Coronary Syndrome Trial: Results With Integrated Collection
Methods and Results In the Apixaban for Prevention of Acute Ischemic Events 2 (APPRAISE?2) trial, patients with a recent acute coronary syndrome were randomized to apixaban or placebo for the prevention of recurrent ischemic events. Suspected end points (myocardial infarction, stroke, or bleeding) were adjudicated by an independent clinical events classification committee.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with André
Contact André, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack